Résumé
Boldenone is banned in the European Union (Directive 96/22/EC) as growth promoter for meat producing animals. Boldione (ADD), boldenone and boldenone esters (mainly the undecylenate form) are commercially available as anabolic preparations, either to the destination of human, horse or cattle. Since the late 90s, the natural occurrence of boldenone metabolites has been reported in cattle. According to EU regulation, the unambiguous demonstration of boldenone administration in bovine urine should be provided on the basis of boldenone identification in the corresponding conjugate fraction. An analytical method has been developed and validated according to current standards with main concern to the measurement of intact 17 beta-boldenone-sulphate. The analytical procedure included direct extraction-purification of target analyte on octadecylsilyl cartridges and direct detection of phase II metabolite by liquid chromatography (negative electrospray), tandem mass spectrometry (QqQ) or high resolution mass spectrometry (Orbitrap(TM)). Decision limit (CC alpha) and detection capability (CC beta) were respectively 0.2 mu g L-1 and 0.4 mu g L-1 on triple quadrupole and 0.1 mu g L-1 and 0.2 mu g L-1 on hybrid system. The method was successfully applied to the analysis of incurred samples collected in different experiments. 17 beta-Boldenone-sulphate was measurable up to 36 h after oral administration of boldione, and 30 days after 17 beta-boldenone undecylenate intra-muscular injection. This conjugate form was never detected in non-treated animals, confirming its status of definitive candidate market for boldenone administration in calf. (C) 2009 Elsevier Inc. All rights reserved.